id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-289599-7vsynfgn	Kostoff, Ronald N.	COVID-19 vaccine safety	2020-09-18		.txt	text/plain	2715	153	45	The present article examines whether short-term, mid-term, and long-term vaccine safety can be achieved under such an accelerated schedule, given the myriad vaccine-induced mechanisms that have demonstrated adverse effects based on previous clinical trials and laboratory research. It is uncertain as to whether any of the drugs, vaccines, foods or radiation exposures of our predecessors, which were not tested for transgenerational effects, are adversely affecting human life at present. Of note, the question remains whether humanity is currently willing to pass on potential devastating diseases to future generations due to the present need for the speedy development of a vaccine, bypassing adequate long-term and transgenerational safety testing. The vaccine costs in this discussion are the potential adverse health effects from a cOVId-19 vaccine, particularly for the mid-and long-term. This least vulnerable demographic population would have to bear the brunt of any potential mid-and long-term adverse health impacts that may result from a vaccine inadequately tested for these effects.	./cache/cord-289599-7vsynfgn.txt	./txt/cord-289599-7vsynfgn.txt